Effect of spinal nitric oxide inhibition on capsaicin-induced nociceptive response

Life Sciences

Volumn 59, Issue 11, 1996, Pages 921-930

  Sakurada, Tsukasa ^a   Sugiyama, Akinori ^b   Sakurada, Chikai ^a   Tan No, Koichi ^b   Yonezawa, Akihiko ^b   Sakurada, Shinobu ^b   Kisara, Kensuke ^b  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antinociception; Capsaicin; Formalin test; L N(G) nitro arginine methyl ester; Nitric oxide synthase; Spinal cord

Indexed keywords

ARGININE; CAPSAICIN; DEXTRO ARGININE; FORMALDEHYDE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030576608     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00390-6     Document Type: Article

References (48)

1. 1. S.R. VINCENT and H. KIMURA, Neuroscience 46 755-784 (1992).
2. 2. J. GARTHWAITE, S L. CHARLES and R. CHESS-WILLIAMS, Nature 336 385-388 (1988).
3. 3. M.A. MARLETTA, J. Biol. Chem. 268 12231-12234 (1993).
4. 4. R.G. KNOWLES and S. MONCADA, Biochem. J. 298 249-258 (1994).
5. 5. D.S. BREDT, P.M. HWANG, C.E. GLATT, C. LOWENSTEIN, R.R. REED and S.H. SNYDER, Nature 351 714-718 (1991).
6. 6. R.M.J. PALMER, D.S. ASHTON and S. MONCADA, Nature 333 664-666 (1988).
7. 7. R.G. KNOWLES, M. PALACIOS, R.M. PALMER and S. MONCADA, Proc. Natl. Acad. Sci. USA 86 5159-5162 (1989).
8. 8. D.D. REES, R.M.J. PALMER, R. SCHULZ, H.F. HODSON and S. MONCADA, Br. J. Pharmacol. 101 746-752 (1990).
9. 9. S.T. MELLER and G.F. GEBHART, Pain 52 127-136 (1993).
10. 10. P.K. MOORE, A.O. OLUYOMI, R.C. BABBEDGE, P. WALLACE and S.L. HART, Br. J. Pharmacol. 102 198-202 (1991).
11. 11. S.T. MELLER, C. DYKSTRA and G.F. GEBHART, Eur. J. Pharmacol. 214 93-96 (1992).
12. 12. K.F. KITTO, J.E. HALEY and G.L. Wilcox, Neurosci. Lett. 148 1-5 (1992).
13. 13. R. PRZEWLOCKI, H. MACHELSKA and B. PRZEWLOCKA, Life Sci. 53 PL1-5 (1993).
14. 14. D.S. BREDT and S.H. SNYDER, Neuron 8 3-11 (1992).
15. 15. J. GARTHWAITE and G. GARTHWAITE, J. Neurochem. 48 29-39 (1987).
16. 16. M. FITZGERALD, Pain 15 109-130 (1983).
17. 17. S.H. BUCK and T.F. BURKS, Pharmacol. Rev. 38 176-226 (1986).
18. 18. C.A. MAGGI and A. MELI, Gen. Pharmacol. 19 1-43 (1988).
19. 19. F. HOLZER, Pharmacol. Rev. 43 143-201 (1991).
20. 20. S. JEFTINIJA, K. JEFTINIJA, F. LIU, S.R. SKILLING, D.H SMULLIN and A.A. LARSON. Neurosci. Lett. 125 191-194 (1991).
21. 21. M. UEDA, Y. KURAISHI and M. SATO, Neurosci. Lett. 155 179-182 (1993).
22. 22. T. SAKURADA, K. KATSUMATA, Y. MANOME, K. TAN-NO, S. SAKURADA and K. KISARA, Neuropharmacology 31 1279-1285 (1992).
23. 23. D. DUBUISSON and S.G. DENNIS, Pain 4 161-174 (1977).
24. 24. J.E. HALEY, A.H. DICKENSON and M. SCHACHTER, Neuropharmacology 31 251-258 (1992).
25. 25. A.B. MALMBERG and T.L. YAKSH, Pain 54 291-300 (1993).
26. 26. T. J. CODERRE and K. YASHPAL, Eur. J. Neurosci. 6 1328-1334 (1994).
27. 27. S.T. MELLER, P.S. PECHMAN, G. F. GEBHART and T.J. MAVES, Neuroscience 50 7-10 (1992).
28. 28. Z. SELTZER, S. COHN, R. GINZBURG and B. BEILIN, Pain 45 69-75 (1990).
29. 29. J.L.K. HYLDEN and G.L. WILCOX, Eur. J. Pharmacol. 67 313-316 (1980).
30. 30. R.-M. BLUTHE, S. SPARBER and R. DANTZER, Neuroreport 3 207-209 (1992).
31. 31. L.F. TSENG, J.Y. XU and G.M. PIEPER, Eur. J. Pharmacol. 212 301-303 (1992).
32. 32. M.L. SEMOS and P.M. HEADLEY, Neuropharmacology 33 1487-1497 (1994).
33. 33. T.L. YAKSH and T.A. RUDY, J. Pharmacol. Exp. Ther. 202 411-428 (1977).
34. 34. T. SAKURADA, T. KATSUMATA, Y. MANOME, K. TAN-NO, S. SAKURADA, K. KISARA and M. OHBA, Eur. J. Pharmacol. 242 47-52 (1993).
35. 35. T. SAKURADA, K. KATSUMATA, H. YOGO, K. TAN-NO, S. SKURADA and K. KISARA, Neurosci. Lett. 151 142-145 (1993).
36. 36. T. SAKURADA, H. YOGO, K. KATSUMATA, K. TAN-NO, S. SAKURADA, K. KISARA and M. OHBA, Brain Res. 649 319-322 (1994).
37. 37. T. OHKUBO, M. SHIBATA, H. TAKAHASHI and R. INOKI, J. Pharmacol. Exp. Ther. 252 1261-1268 (1990).
38. 38. L.S. SORKIN and D.J. MCADOO, Brain Res. 607 89-98 (1993).
39. 39. T. SAKURADA, A. SUGIYAMA, K. TANNO. S. SAKURADA and K. KISARA, The ninth rinshoken international conference-Excitatory amino acids approaches to clinical uses, Abstracts P19, Tokyo (1994).
40. 40. M.B. BAUER, M.L. SIMMONS, S. MURPHY and G.F. GEBHART, J. Neurosci. Res. 3 280-289 (1993).
41. 41. V. RADHAKRISHNAN and J.L. HENRY, Neuroreport 4 323-326 (1993).
42. 42. Y. AIMI, M. FUJIMURA, S.R. VINCENT and H. KIMURA, J. Comp. Neurol. 306 382-392 (1991).
43. 43. L.M. AANONSEN and G.L. WILCOX, J. Pharmacol. Exp. Ther. 243 9-19 (1987).
44. 44. P.M.B. CAHUSAC, R.H. EVANS, R.G. HILL, R.E. RODRIQUEZ and D.A.S. SMITH, Neuropharmacology 23 719-724 (1984).
45. 45. A.H. DICKENSON and E. AYDAR, Neurosci. Lett. 121 263-266 (1991).
46. 46. G. RAIGORODSKY and G. URCA, Brain Res. 422 158-162 (1987).
47. 47. T. SAKURADA, Y. MANOME, K. TAN-NO, S. SAKURADA and K. KISARA , Br. J. Pharmacol. 101 307-310 (1990).
48. 48. J. GARTHWAITE, Trends. Neurosci. 14 60-67 (1991).